Comparing DNA Nanobots to Immunotherapy
While immunotherapy harnesses the body’s immune system to fight cancer, DNA nanobots work independently, acting as programmed agents that specifically target tumor cells. Unlike immunotherapies, which can sometimes trigger unwanted immune responses or inflammation, nanobots offer tighter control and greater specificity. They can be engineered to recognize only cancerous markers, minimizing risks of immune-related side effects. This distinction makes DNA nanobot technology a promising alternative—or complement—to existing cancer therapies.